Pharmacological inhibition of TRα1 receptor potentiates the thyroxine effect on body weight reduction in rats: Potential therapeutic implications in controlling body weight

C. Pantos, I. Mourouzis, I. Paizis, V. Malliopoulou, Ch Xinaris, P. Moraitis, A. D. Cokkinos, D. V. Cokkinos

Research output: Contribution to journalArticlepeer-review

Abstract

It has been previously reported that thyroid hormone receptor α1 (TRα1) is involved in the regulation of food intake and heart rhythm. Herein, we show that pharmacological inhibition of TRα1 by dronedarone, an amiodarone like compound (shown to antagonize thyroid hormone binding to TRα1), prevented the thyroid hormone induced increase in food intake and heart rate acceleration in rats. This resulted in a marked reduction in body weight. It is likely that thyroid analogs may prove potential therapeutic agents for controlling body weight.

Original languageEnglish
Pages (from-to)136-138
Number of pages3
JournalDiabetes, Obesity and Metabolism
Volume9
Issue number1
DOIs
Publication statusPublished - Jan 2007
Externally publishedYes

Keywords

  • Body weight
  • Obesity
  • Rats
  • Thyroid analogs
  • Thyroxine

Fingerprint

Dive into the research topics of 'Pharmacological inhibition of TRα1 receptor potentiates the thyroxine effect on body weight reduction in rats: Potential therapeutic implications in controlling body weight'. Together they form a unique fingerprint.

Cite this